Abstract:Cardiac hypertrophy (CH) is an enormous risk factor in the process of heart failure development, however, there is still lack of effective treatment for CH. Mitochondrial protection is an effective way against CH. Rheum palmatum L. (rhubarb) has been used to treat chronic heart diseases such as heart failure, especially to inhibit cardiac compensatory enlargement. The aim of this study was to explore the pharmacodynamic component of rhubarb and reveal its pharmacological effects and targets in the treatment of CH. Based on network pharmacology and machine learning approach, ingredients of rhubarb and targets for CH were extracted and surflex docking was conducted for obtaining the optimal ingredient-target combination(s) and emodin-SIRT3 was identified for further functional analysis. Transverse aortic constriction or isoproterenol induced CH mice and phenylephrine injured cardiomyocytes were used to verify the mitochondria protection effect and CH improvement of emodin in vivo and in vitro by modulation of mitochondrial SIRT3 signaling. The results showed that emodin could block agonist-induced and pressure overload-mediated CH. Emodin prevented mitochondrial dysfunction and its underlying mechanism was attributed to the activation of SIRT3, but the effect was not obvious with the presence of SIRT3 inhibitors (3-TYP)/SIRT3 siRNA. Furthermore, PGC-1ɑ was involved in the process of emodin regulating SIRT3 signaling pathway as an upstream target. Our findings clarified the main material basis and mechanism of rhubarb in the treatment of CH. Emodin, as the major ingredient of rhubarb, has therapeutic potential for CH through mitochondrial protection due to the modulation of SIRT3 signaling.

The possible mechanism of inhibiting smooth muscle cell proliferation by Emodin

[Inhibitory effects of emodin on proliferation of rat vascular smooth muscle cell induced by angiotensin II].

Inhibitory effects of emodin on the proliferation of cultured rat vascular smooth muscle cell-induced by angiotensin II.

Effects of Dimethylsulfoxide (Dmso)-Soluble Particles from Cigarette Smoke on the Proliferation of Vascular Smooth Muscle Cell

Effect of Emodin on NO-cGMP Signal Pathway in Rat Vascular Endothelium in Vitro

A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling

Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.

Emodin in Atherosclerosis Prevention: Pharmacological Actions and Therapeutic Potential

Effect of Aloe-Emodin on c-myc Gene Expression of Cultured Vascular Smooth Muscle Cells of Injuried Artery

Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug

Effect of Emodin on Expression of CyclinD1 of Human Vascular Smooth Muscle Cells

Involvement of p53-dependent pathway in the antiproliferative activity of emodin in human smooth muscle cell]

Endotheliaum-Independent Vasorelaxation Effect of Emodin on Rat Aortic Rings and Its Mechanism

Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro

Different Effects Of Angiotensin Ii And Angiotensin-(1-7) On Vascular Smooth Muscle Cell Proliferation And Migration

Andrographolide Promotes Interaction Between Endothelin-Dependent EDNRA/EDNRB and Myocardin-SRF to Regulate Pathological Vascular Remodeling

Role of emodin in atherosclerosis and other cardiovascular diseases: Pharmacological effects, mechanisms, and potential therapeutic target as a phytochemical

Emodin in cardiovascular disease: The role and therapeutic potential

Inhibitory Activity of Astragaloside Ⅳ on Proliferation of Aorta Vascular Smooth Muscle Cells in Rats

Aloe-emodin derivative produces anti-atherosclerosis effect by reinforcing AMBRA1-mediated endothelial autophagy

Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia